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Abstract: 
Oxidative stress and free radical production have been implicated in Alzheimer‟s 
disease, where low levels of the antioxidant vitamin C (ascorbate) have been shown to 
be associated with the disease. In this study, neuroblastoma SH-SY5Y cells were 
treated with hydrogen peroxide in the presence of ascorbate in order to elucidate the 
mechanism(s) of protection against oxidative stress afforded by ascorbate. Protein 
oxidation, glutathione levels, cell viability and the effects on the proteome and its 
oxidized counterpart were monitored. SH-SY5Y cells treated with ascorbate prior to 
co-incubation with peroxide showed increased viability in comparison to cells treated 
with peroxide alone. This dual treatment also caused an increase in protein carbonyl 
content and a decrease in glutathione levels within the cells. Proteins, extracted from 
SH-SY5Y cells that were treated with either ascorbate or peroxide alone or with 
ascorbate prior to peroxide, were separated by 2DE and analysed for oxidation. Co-
incubation for 24 hours decreased the number of oxidised proteins (e.g. Acyl CoA 
oxidase 3) and induced brain derived neurotrophic factor (BDNF) expression. 
Enhanced expression of BDNF may contribute towards the protective effects of 
ascorbate against oxidative stress in neuronal cells.  
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Introduction: 
Oxidative damage to proteins, lipids and DNA has been observed in many chronic 
inflammatory and degenerative diseases [1,2]. These findings implicate oxidative 
stress in the disease processes, where oxidative stress arises from an imbalance 
between the rate of oxygen free radical generation, and their removal by low 
molecular weight scavengers and antioxidant enzymes [3]. The sources of oxygen 
radicals are diverse in pathophysiology, where they can arise from both endogenous 
and exogenous processes [4]. Three mechanisms have been proposed to account for 
elevated oxidative stress in neurodegenerative disease; the mitochondrial hypothesis 
where defects in the respiratory chain leads to electron loss and oxygen radical 
formation [5], the response to injury hypothesis where a brain inflammatory response 
may explain neuronal damage [6] and the generation of peroxides from beta amyloid 
fragments [7,8]. 
 
The brain is particularly vulnerable to oxygen radical damage, through the prevalence 
of oxidizable polyunsaturated fatty acids in membranes, the presence of redox active 
metal ions and the high metabolic requirement for oxygen [9]. Normally, neuronal 
cells accumulate high levels of the antioxidant ascorbic acid, and synthesize greater 
amounts of glutathione than other cells [10]. Indeed, glutathione and ascorbate are 
reciprocally linked, where glutathione is important in regenerating ascorbate from its 
oxidised form [4]. However, epidemiological evidence in elderly subjects has shown 
lower plasma levels of antioxidants such as ascorbate [11], and an inverse relationship 
exists between ascorbate levels and Alzheimer disease incidence [12, 13]. 
Furthermore, in a clinical trial, the antioxidant efficacy of vitamin E was augmented 
by co-supplementation with ascorbate [14]. 
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In vitro studies have confirmed the importance of ascorbate as a protective molecule 
against oxidative stress induced neurotoxicity. Studies by McGregor et al. [15] have 
demonstrated that kainiate induced excitoxicity in the hippocampus can be 
ameliorated in the rat by dosing with vitamin C. A high concentration of ascorbate 
(1.5mM) prevented malondialdehyde formation in rat brain microsomes [16]. It has 
been shown that large amounts of ascorbate added to brain slices prevent subsequent 
oedema formation [17]. Li et al. [18] have also suggested that intracellular ascorbate 
is an effective antioxidant in neuronal cells (SH-SY5Y), and these findings support a 
role for ascorbate in protecting neurones from oxidant damage associated with various 
neurodegenerative diseases. Recent studies investigating the mechanisms of 
cytoprotection afforded by “antioxidants” such as ascorbate have suggested that their 
effects may not only lie in their capacity to reduce oxygen radicals, but also in their 
capacity to elicit expression of other cytoprotective molecules [19, 20]. Therefore, we 
have investigated the hypothesis that ascorbate protects against oxidative stress by 
preventing protein oxidation and inducing cellular protection mechanisms. 
 
In this work, we have examined the protective effect of vitamin C against loss of 
glutathione and induction of protein carbonyls by hydrogen peroxide in 
neuroblastoma cells, and its capacity to elicit protection through the neuronal 
proteome using 2-dimensional gel electrophoresis. 
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Methods: 
Cell culture: 
Neuroblastoma cells (SH-SY5Y) were cultured using RPMI 1640 with Glutamax I 
(Gibco) supplemented with fetal bovine sera (15%, Gibco), non-essential amino acid 
solution (1%, Sigma) and penicillin (0.5U/ml, Gibco) and streptomycin (0.5mg/ml, 
Gibco). Cells were maintained in 75cm
2
 flasks until confluent.  
 
A 4-hour adaptive phase was allowed prior to start of treatments to allow for 
normalization of transient redox flux and loss of glutathione (GSH) that is associated 
with passage. SH-SY5Y cells were subject to 4 paradigms: 1, the true control, which 
had no oxidative stress or antioxidant added; 2, cells were treated with ascorbate (50-
100) at 4h after seeding; 3, cells were treated with hydrogen peroxide (50-500M) 
at 24h after seeding; and 4, cells were treated with ascorbate (100M) 4h after 
seeding and then with hydrogen peroxide (100M) at 24h after seeding. All four 
paradigms were incubated for 48h. 
 
Cell viability: 
Triplicate samples of SH-SY5Y cells (2 x 10
5
 per well) were seeded in 96-well plates 
and subjected to the oxidative stress/ antioxidant conditions described. Cell viability 
was measured as described by Hansen et al. [21]. Briefly, two hours prior to the 
completion of the experiment 3(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium 
(MTT solution;25l, 5mg/ml) was added to the wells. The cells were then incubated 
at 37°C for 2h before addition of lysis buffer (100l SDS (20%), dimethylformamide 
(50%), pH4.7 with acetic acid). Formazan release was read (570nm) after 16h at 37°C 
in a Dynex plate reader.  
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Protein assay: 
Protein content was determined by the bichinchoninic acid assay [22].  
 
Glutathione assay: 
Triplicate samples of SH-SY5Y cells (2x105) were harvested after exposure to 
oxidative stress and antioxidants for the varying times and doses described. 
Glutathione levels were measured as described by Punchard et al. [23]. Briefly, cells 
were washed in PBS and pelleted prior to protein precipitation and extraction with 
sulfosalicylic acid (3.3l, 100%w/v). After centrifugation, 125mM sodium phosphate 
with 6.3mM EDTA (96.6l, pH 7.5) was added. Extracts (25l) were aliquoted into 
96-well plates. To each well NADPH (150l, 0.3mg/ml, dissolved in 125mM sodium 
phosphate with 6.3mM EDTA pH7.5) and 5,5‟-dithio-bis(2-nitrobenzoicacid) 3-
carboxy-4-nitrophenyl disulphid (DTNB) (50l, 6mM DTNB in 125mM sodium 
phosphate with 6.3mM EDTA pH7.5) solutions were added. Glutathione reductase 
(25l, 20U/ml, Sigma) was added to each well and absorbance change (410nm) was 
recorded every 5min in a Dynex plate reader. Glutathione standards were prepared (0-
2.5nmol/well) and treated in the same manner. Data are expressed as nmol glutathione 
per mg protein in order to correct for any variability in cell number dictated by cell 
treatment. 
 
Carbonyl ELISA: 
Proteins (1g per well) from treated and control SH-SY5Y cells were bound to a 
Nunc immunosorb 96 well plate and carbonyl groups were derivatized with reduced 
dinotrophenylhydrazine (DNPH) prior to identification by a mouse monoclonal anti-
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DNP-antibody and secondary peroxidase coupled anti-mouse-antibody [24]. Data is 
expressed as nmol carbonyl per mg protein. This takes into account variability in cell 
number and protein loss through cell death. 
 
Extraction of proteins: 
SH-SY5Y cells (10x106) were harvested and then solubilized in rehydration buffer 
(urea (5M), thiourea (2M) CHAPS (2%), SB3-10 (2%), TBP (2mM), Tris HCl 
(40mM) and Biolytes 3/10 (0.5%)) by sonication (15min). The protein content of 
these preparations was determined by RCDC protein assay (BioRad). 
 
Focussing of samples: 
Immobilised pH gradient (IPG) strips (11cm, pH 3-10, BioRad) were used to separate 
proteins in the first dimension. Prepared proteins (50g) were applied during 
rehydration to the IPG strips in rehydration buffer (180l, 16h, 20°C). Proteins were 
focused on a Multiphor II with a DryStrip Kit and power was supplied by an EPS 
3500XL power pack (Amersham Pharmacia Biotech), cooled to 20°C (Grant cooling 
system). The running conditions were: a gradient of 0V to 500V over 500Vh, 500V to 
3500V for 3500Vh and finally 3500V for 90kVh. After focusing the IPG strips were 
stored at –70°C until required. 
 
2DE: 
Prior to the second dimension IPG strips were equilibrated in equilibration 
buffer (urea (6M), glycerol (20%), SDS (2%), tributyl phosphine (TBP;5mM), Tris 
(0.375M) pH 8.8) for 20min [25]. After equilibration IPG strips were placed above a 
4-20% gradient gel (BioRad) and set in agarose (1%, in Tris/glycine/SDS (TGS) 
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buffer (BioRad)). The proteins were electrophoresed in BioRad Critterion kit for 
70min at 150V, using TGS buffer (BioRad). Gels were then either stained with silver 
[26] or immunoblotted as described. Silver stained gels were analysed with PDQuest 
software (BioRad). Changes in protein expression were identified using Boolean 
interrogation. Protein spots were thus identified as (1) those which were present 
throughout control, ascorbate and/or peroxide treatment (2) those that showed altered 
expression, and (3) those which were only present upon treatment. Changes in 
expression were subject to statistical analyses within the software, allowing fold 
changes in expression to be identified. Protein spots that showed a fold change of 5, 
where the set included proteins spots whose quantity in treated cells was at least 5 
times that of the corresponding spot in non-treated cells, were selected for further 
study. 
 
Immunoblotting and detection of oxidized proteins: 
Second dimension gels were transferred to a Hybond-P (PVDF) membrane 
(Amersham Pharmacia Biotech) using a BioRad Critterion Western Blotter kit for 2h 
at 170mA. After transfer the membrane was blocked in TBS-Tween-20 (0.5%) 
overnight. Membranes were then probed using an indirect method with for carbonyl 
groups with an anti-DNP antibody (1:2000, mouse monoclonal, Sigma) after 
sensitisation of carbonyl groups with 25mM DNPH. The primary antibody was 
detected with an anti-mouse peroxidase-conjugated antibody (1:4000, goat, Sigma). 
Oxidized proteins were visualized with ECL plus (Amersham Pharmacia Biotech). 
Films of each blot were analysed with PDQuest (BioRad) after scanning on a GS-710 
Densitometer. After detection antibodies were removed with Restore buffer (Pierce) 
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and proteins on the blot were detected with colloidal gold stain (Aurodye Forte, 
Amersham Pharmacia Biotech). 
 
Identification of proteins: 
For all protein identification by mass fingerprinting, 6 gels were run and relevant 
spots from all gels were pooled to gain sufficient quantities. Second dimension gels 
were silver stained [26], proteins of interest were excised and tryptically digested as 
described by Gharahdagli et al. [27]. Peptides were extracted from the gel pieces as 
described by Hellman et al. [28]. Peptides were desalted with C18 ZipTips (Millipore) 
and mass fingerprints were produced at Alta Bioscience (Birmingham UK) by 
MALDI-TOF MS on a SIA (Manchester) LT3 LazerTOF with a nitrogen laser. The 
MS data were searched against a subset of human proteins in the MSDB database 
using the Mascot search program (Matrix Science, London, UK, 
www.matrixscience.com). Positive protein identification was based on standard 
Mascot criteria for statistical analysis. 
 
Immunoblotting 
Cell extract (20g) was separated by SDS-PAGE on 12.5% polyacrylamide gels. 
After transfer to PVDF membrane BDNF protein was selectively detected using a 
mouse monoclonal antibody directed against human BDNF (Abcam). A monoclonal 
antibody to mouse IgG conjugated to peroxidase (Sigma) and the ECL plus system 
(APBiotech) was used to visualize BDNF signals. To demonstrate equal protein 
loading blots were analysed with an antibody against -actin (Abcam). 
 
Statistics 
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For biochemical assays, data are reported from three independent experiments. Data 
was evaluated statistically for multi-comparison using ANOVA with Dunnet‟s post 
test, where p≤0.05 was considered significant. For 2DE, cell extracts from six 
independent experiments were analysed. 
 
 
 12 
 
Results: 
Incubation of SH-SY5Y cells with hydrogen peroxide decreased cell viability in a 
dose dependent manner. No significant decrease in viability was seen following 
treatment with 100M hydrogen peroxide (24h) but at 250µM a 69% reduction in 
viability that progressed to 92% after 500M hydrogen peroxide treatment was 
observed (Figure 1). However, preincubation of SH-SY5Y cells with 100M 
ascorbate for 24h prior to co-incubation with peroxide (100 or 500µM) protected cell 
viability over the following 24h period. Ascorbate alone (50µM and 100µM) did not 
have any significant effect on SH-SY5Y cell viability (Figure 1). None of the 
peroxide treatments described had any significant effect on the oxidation of proteins 
as seen by carbonyl ELISA, despite a trend to increasing carbonyl with increasing 
peroxide. Neither did ascorbate alone exert any significant change in the amount of 
oxidized proteins at 48h (Figure 2). Nevertheless, the presence of ascorbate (50 or 
100µM) was seen to significantly inhibit carbonyl formation in peroxide (250 and 
500µM) treated cells. Similarly, intracellular glutathione levels were not significantly 
altered at 48h by subjecting SH-SY5Y cells to the oxidative stress conditions 
described (Figure 3). However, co-incubation with ascorbate (100µM) and peroxide 
(500µM) did significantly reduce GSH content. 
Separation of proteins by 2-dimensional polyacrylamide gel electrophoresis extracted 
from SH-SY5Y cells provided a more detailed analysis of the effects of ascorbate and 
peroxide (Figure 4). Proteins were immunoblotted after 2D-PAGE and probed for 
carbonyl groups, after derivitization with DNP, with antibody (anti-DNP), a marker of 
oxidative stress. In untreated cells, only 4 proteins were identified as oxidized under 
the conditions employed. The same proteins were oxidized in peroxide treated cells 
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and in cells pretreated with ascorbate. However, in extracts from cells treated with 
ascorbate followed by peroxide only one oxidized protein was detected (Table 1). 
Intensity changes in the four spots are reported in Table 2. The protein consistently 
oxidized (Figure 4) in all situations was identified by MALDI-TOF as collagen 
(sequence coverage 28%), from parallel silver stained gels. Only one of the other 
three proteins () in the oxidized proteome was identified, from silver stained gels as 
acyl CoA oxidase 3 (sequence coverage 15%).  There was insufficient protein per spot 
for mass fingerprinting of the other spots. After immuno-probing, blots were stripped 
of antibodies and proteins were stained with colloidal gold. Analysis of these 
expressed proteome blots showed that one protein in the SH-SY5Y cells treated with 
both ascorbate and hydrogen peroxide was induced by the treatment, in comparison to 
control cells and cells treated with only the stressor or the antioxidant (Table 1). 
Protein, extracted from parallel gels that were silver stained, allowed for identification 
of this induced protein by mass fingerprinting as brain derived neurotrophic factor 
(BDNF) (sequence coverage 29%). Further confirmation of this observation was 
achieved by immunoblotting (Figure 5), where little or no signal for BDNF was 
observed in control, ascorbate or peroxide treated cells despite equivalent protein 
loading (actin levels were equivalent through all treatment). In contrast, cells 
pretreated with ascorbate prior to exposure to hydrogen peroxide showed significant 
upregulation of BDNF expression. 
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Discussion: 
The present study shows that peroxide induced cell death in a dose dependent manner 
in SH-SY5Y neuroblastoma cells. Ascorbate counteracted peroxide toxicity with the 
most significant protection afforded by 100M ascorbate. At this concentration of 
ascorbate, cellular respiration was apparently enhanced over control indicative of 
growth promotion.  Whilst little protective effect of ascorbate was seen against 
250µM peroxide (probably due to greater variability in cell death according to 
confluence of cells prior to treatment) a significant protective effect was seen against 
protein carbonyl formation under extreme conditions, where greater than 50% of the 
cells were dead. When the cells were treated with 100M peroxide or less, no change 
in carbonyl was seen at 24h, possibly reflecting early removal of oxidized proteins by 
the 20S proteasome, which predominantly removes and degrades oxidized proteins. 
Grune et al. [29] showed that hydrogen peroxide induced protein degradation over 
control in C9 liver cells, which was inhibited by lactacystin, indicating a pathway 
through via the 20S proteasome. Davies [30] also demonstrated that hydrogen 
peroxide increased protein degradation in C9 cells, which could be prevented by 
immunoprecipitation of the 20S proteasome. Furthermore, Ernst et al [31] 
demonstrated that an increase in carbonyl content in OLN 93 cells is associated with 
an increase in proteolytic activity, when treated with hydrogen peroxide (100µM).  
The fate of ascorbate and glutathione are linked within the cell. Recycling of 
dehydroascorbate by the loss of glutathione produces ascorbate once more that can 
„mop-up‟ reactive oxygen species within a cell. Uptake of ascorbate into the cell is via 
the GLUT receptor after the extracellular conversion of ascorbate to dehydroascorbate 
or by direct up-take of ascorbate via sodium dependent ascorbate transfer or 
glutamate–ascorbate heteroexchange [32-34]. However, the former is much more 
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efficient. Indeed, Long and Halliwell [35] showed that the addition of ascorbate to 
cell culture medium could produce hydrogen peroxide. Herein, we detected a drop in 
glutathione levels after addition of peroxide to cells and at the same time an increase 
of protein. These changes may stimulate the cell into a mildly stressed state that may 
elicit protection against oxidative stress, ultimately resulting in increased cell 
viability.  
 
The analysis of protein oxidation and expression, as seen by 2D-PAGE, showed a 
reduction in the number of oxidized proteins (four proteins to one) and an induction of 
one protein when cells were pretreated with ascorbate followed by peroxide. Two of 
the oxidized proteins were identified: collagen was constitutively oxidized; whilst the 
oxidation of acyl CoA oxidase 3 was reduced by ascorbate. The abundance of 
collagen as a mechanical cellular component with a low turnover may explain the 
consistent oxidation of this protein, or this may be an illustration of the oxidation of 
new collagen being formed within the cells as is the norm with collagen synthesis. 
Acyl CoA oxidase 3 is involved in  oxidation, the metabolism of fatty acids. One of 
the products of the enzyme reaction is hydrogen peroxide. This may be the cause of 
the oxidative damage even in untreated cells. In addition this enzyme has an important 
role in the detoxification of lipid peroxides [36]. The inclusion of ascorbate and 
hydrogen peroxide may induce repair mechanisms that allow for a higher turnover of 
protein and hence the reduction of oxidation. Pratt et al. [37] recently illustrated that 
protein turnover can occur art an average rate of 2.2%/h, with highest degradation 
rates of 10%/h. After 24h, based on these figures, a turnover of 10% would leave only 
8% of the original population of a particular protein. If the turnover was increased by 
the conditions described here any initially damaged proteins would be cleared rapidly. 
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Indeed, Ullrich and Grune [38] have demonstrated that 70% of oxidized nuclear 
proteins are removed after 24h, in comparison to 20% in control cells. 
 
One protein was induced by in cells incubated with ascorbate followed with hydrogen 
peroxide. This was identified as BDNF by MALDI-TOF MS and immunoblotting. 
The immunoblot indicates that there is minimal/no expression of BDNF in any cells 
except the cells receiving combined ascorbate and hydrogen peroxide within the 
detection limits of the assays utilised in this study.   BDNF supports cell survival via a 
variety of pathways downstream of Trk B interaction, including upregulation of 
superoxide dismutase, glutathione reductase, glutathione peroxidase [39], and 
activation of the Ras-MAPkinase survival pathway [40,41]. Furthermore, BDNF has 
been previously shown to activate glutathione reductase in SH-SY5Y cells ensuring 
protection against ROS and the resultant oxidative stress [42]. We investigated the 
levels of BDNF receptor in neuroblastoma cells by ELISA and found low levels of 
Trk B (BDNF receptor) were expressed in untreated SH-SY5Y cells. Furthermore, 
addition of BDNF (10ng/ml) for 24h reduced apoptosis (assessed by flow cytometry) 
induced by 100M peroxide from 35% to 25% compared to cells treated with 
peroxide alone (data not shown).  
 
These findings suggest that the protective effect of ascorbate in vitro may partly be 
due to the increased expression of BDNF, which may in turn activate a cascade of 
antioxidant defence mechanisms. The importance of acorbate in eliciting this 
protective pathway in vitro remains to be determined.  
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Legends  
 
Table 1. Effect of peroxide and ascorbate on the number of proteins showing 
oxidation and increased expression.   
 
Table 2. Relative intensities of the four proteins affected by oxidation determined 
using PD-Quest. Data shown are from one representative carbonyl blot. 
 
Figure 1. Effect of peroxide and ascorbate on cell viability measured by MTT assay 
SH-SY5Y cells (2000 per well) were seeded in 96 cell plates. Cells were treated with  
hydrogen peroxide (0-500M, 24h), in the presence or absence of  ascorbate (50-
100M, 48h). Cell viability was measured as described by Hansen et al. (1989) [16].  
Statistical significance test by ANOVA with Dunnet‟s post test (* p<0.05, **p<0.01).  
 
Figure 2. Effect of peroxide and ascorbate on carbonyl content measured by carbonyl 
ELISA. Protein (25g) was extracted from SH-SY5Y cells (2x105) that had been 
treated with  hydrogen peroxide (0-500M, 24h), in the presence or absence of  
ascorbate (50-100M, 48h) were utilized in a carbonyl ELISA as described by Carty 
et al. (2000) [19]. Statistical significance test by ANOVA with Dunnet‟s post test (* 
p<0.05, **p<0.01). 
 
Figure 3. Effect of peroxide and ascorbate on intracellular GSH levels measured by 
GSH assay. (** p<0.01). Glutathione levels were determined in SH-SY5Y cells 
(2x10
5
) that had been treated with  hydrogen peroxide (0-500M, 24h), in the 
presence or absence of  ascorbate (50-100M, 48h) as described by Punchard et al. 
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(1994) [18]. Statistical significance test by ANOVA with Dunnet‟s post test (* 
p<0.05, **p<0.01). 
 
Figure 4.(a) 2D-PAGE of ascorbate (100µM, 48h) and peroxide (100µM, 24h) treated 
SH-SY5Y neuroblastoma cells. (b) magnified areas of 2D-PAGE shown in (a) 
showing oxidized proteins. (c) magnified areas of 2D-PAGE shown in (a) showing 
gold stained proteins highlighting an induced protein. (d) Mass spectrum for oxidized 
protein   (shown in b) identified as collagen. (e) Mass spectrum for oxidized protein 
  (shown in b) identified as acyl CoA oxidase3. (f) Mass spectrum for induced 
protein  (shown in c) identified as BDNF. 
 
Figure 5. Immunoblots of cell extracts following incubation with ascorbate (100µM, 
48h) and /or peroxide (100µM, 24h). Protein was separated on 12.²% SDS-PAGE gels 
and transferred to PVDF membrane. Membranes were probed with anti-human 
BDNF, where human BDNF was run as a positive control. Blots were probed for -
actin to demonstrate equal protein loading.  
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    
Control 260 25 92 90 
100µM peroxide 91 21 67 73 
100µM Ascorbate + 
100µM peroxide 
671 - - - 
100µM Ascorbate 314 11 16 58 
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